AUTH:"Madar C" - Search results

Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials.

Siempos II, Kalil AC, Belhadi D, Veiga VC, Cavalcanti AB, Branch-Elliman W, Papoutsi E, Gkirgkiris K, Xixi NA, Kotanidou A, Hermine O, Porcher R, Mariette X, CORIMUNO-19 Collaborative Group, DisCoVeRy Study Group, ACTT-2 Study Group, ACTT-3 Study Group

EClinicalMedicine, 69:102472, 09 Feb 2024

Cited by: 0 articles | PMID: 38361992 | PMCID: PMC10867612

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Peripapillary hyperreflective ovoid mass-like structures and the retinal nerve fiber layer thinning.

Rabinovich M, Seray S, Amoroso F, Madar C, Souied EH

Eur J Ophthalmol, 34(2):NP126-NP130, 31 Oct 2023

Cited by: 2 articles | PMID: 37904532

Add to export list

Decreased Self-reported Physical Fitness Following SARS-CoV-2 Infection and the Impact of Vaccine Boosters in a Cohort Study.

Richard SA, Scher AI, Rusiecki J, Byrne C, Berjohn CM, Fries AC, Lalani T, Smith AG, Mody RM, Ganesan A, Huprikar N, Colombo RE, Colombo CJ, Schofield C, Lindholm DA, Mende K, Morris MJ, Jones MU, Flanagan R, [...] EPICC COVID-19 Cohort Study Group

Open Forum Infect Dis, 10(12):ofad579, 17 Nov 2023

Cited by: 0 articles | PMID: 38130596 | PMCID: PMC10733205

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Weakly Semi-Supervised Detection in Lung Ultrasound Videos

Ouyang J, Chen L, Li GY, Balaraju N, Patil S, Mehanian C, Kulhare S, Millin R, Gregory KW, Gregory CR, Zhu M, Kessler DO, Malia L, Dessie A, Rabiner J, Coneybeare D, Shopsin B, Hersh A, Madar C, [...] Chen A

arXiv, 08 Aug 2023

Cited by: 0 articles | PPR: PPR704005

Add to export list Preprint v1

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Understanding "Hybrid Immunity": Comparison and Predictors of Humoral Immune Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) Vaccines.

Epsi NJ, Richard SA, Lindholm DA, Mende K, Ganesan A, Huprikar N, Lalani T, Fries AC, Maves RC, Colombo RE, Larson DT, Smith A, Chi SW, Maldonado CJ, Ewers EC, Jones MU, Berjohn CM, Libraty DH, Edwards MS, [...] and Clinical Characteristics of Emerging Infectious Diseases with Pandemic Potential COVID-19 Cohort Study Group

Clin Infect Dis, 76(3):e439-e449, 01 Feb 2023

Cited by: 26 articles | PMID: 35608504 | PMCID: PMC9213853

Add to export list Free full text in Europe PMC

Persistent COVID-19 Symptoms at 6 Months After Onset and the Role of Vaccination Before or After SARS-CoV-2 Infection.

Richard SA, Pollett SD, Fries AC, Berjohn CM, Maves RC, Lalani T, Smith AG, Mody RM, Ganesan A, Colombo RE, Lindholm DA, Morris MJ, Huprikar N, Colombo CJ, Madar C, Jones M, Larson DT, Bazan SE, Mende K, [...] and Clinical Characteristics of Emerging Infectious Diseases With Pandemic Potential (EPICC) COVID-19 Cohort Study Group

JAMA Netw Open, 6(1):e2251360, 03 Jan 2023

Cited by: 27 articles | PMID: 36652247 | PMCID: PMC9857077

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Distinct blood inflammatory biomarker clusters stratify host phenotypes during the middle phase of COVID-19.

Blair PW, Brandsma J, Chenoweth J, Richard SA, Epsi NJ, Mehta R, Striegel D, Clemens EG, Alharthi S, Lindholm DA, Maves RC, Larson DT, Mende K, Colombo RE, Ganesan A, Lalani T, Colombo CJ, Malloy AA, Snow AL, [...] EPICC COVID-19 Cohort Study Group

Sci Rep, 12(1):22471, 28 Dec 2022

Cited by: 2 articles | PMID: 36577783 | PMCID: PMC9795438

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

[Junctional scotoma of Traquair as presenting sign of a pituitary adenoma].

Madar C, de Faria A, Delbarre M, Froussart Maille F

J Fr Ophtalmol, 46(3):305-307, 16 Jan 2023

Cited by: 0 articles | PMID: 36653252

Add to export list

An Analysis of SARS-CoV-2 Vaccine Reactogenicity: Variation by Type, Dose, and History, Severity, and Recency of Prior SARS-CoV-2 Infection.

Scher AI, Berjohn CM, Byrne C, Colombo RE, Colombo CJ, Edwards MS, Ewers EC, Ganesan A, Jones M, Larson DT, Libraty D, Lindholm DA, Madar CS, Maldonado CJ, Maves RC, Mende K, Richard SA, Rozman JS, Rusiecki J, [...] EPICC COVID-19 Cohort Study Group

Open Forum Infect Dis, 9(7):ofac314, 28 Jun 2022

Cited by: 3 articles | PMID: 35899278 | PMCID: PMC9278193

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

COVID-19 Patient-Reported Symptoms Using FLU-PRO Plus in a Cohort Study: Associations With Infecting Genotype, Vaccine History, and Return to Health.

Richard SA, Epsi NJ, Lindholm DA, Malloy AMW, Maves RC, Berjohn CM, Lalani T, Smith AG, Mody RM, Ganesan A, Huprikar N, Colombo RE, Colombo CJ, Madar C, Jones MU, Larson DT, Ewers EC, Bazan S, Fries AC, [...] EPICC COVID-19 Cohort Study Group

Open Forum Infect Dis, 9(7):ofac275, 07 Jun 2022

Cited by: 5 articles | PMID: 35873301 | PMCID: PMC9214183

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

COVID-19 Outcomes Among US Military Health System Beneficiaries Include Complications Across Multiple Organ Systems and Substantial Functional Impairment.

Richard SA, Pollett SD, Lanteri CA, Millar EV, Fries AC, Maves RC, Utz GC, Lalani T, Smith A, Mody RM, Ganesan A, Colombo RE, Colombo CJ, Lindholm DA, Madar C, Chi S, Huprikar N, Larson DT, Bazan SE, [...] EPICC COVID-19 Cohort Study Group

Open Forum Infect Dis, 8(12):ofab556, 10 Nov 2021

Cited by: 13 articles | PMID: 34909439 | PMCID: PMC8664684

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Performance of the inFLUenza Patient-Reported Outcome Plus (FLU-PRO Plus) Instrument in Patients With Coronavirus Disease 2019.

Richard SA, Epsi NJ, Pollett S, Lindholm DA, Malloy AMW, Maves R, Utz GC, Lalani T, Smith AG, Mody RM, Ganesan A, Colombo RE, Colombo CJ, Chi SW, Huprikar N, Larson DT, Bazan S, Madar C, Lanteri C, [...] and Clinical Characteristics of Pandemic Infectious Diseases (EPICC) COVID-19 Cohort Study Group

Open Forum Infect Dis, 8(12):ofab517, 08 Oct 2021

Cited by: 15 articles | PMID: 34901299 | PMCID: PMC8661080

Add to export list Free full text in Europe PMC

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA Vaccine-Breakthrough Infection Phenotype Includes Significant Symptoms, Live Virus Shedding, and Viral Genetic Diversity.

Pollett SD, Richard SA, Fries AC, Simons MP, Mende K, Lalani T, Lee T, Chi S, Mody R, Madar C, Ganesan A, Larson DT, Colombo CJ, Colombo R, Samuels EC, Broder CC, Laing ED, Smith DR, Tribble D, [...] Burgess TH

Clin Infect Dis, 74(5):897-900, 01 Mar 2022

Cited by: 20 articles | PMID: 34117878 | PMCID: PMC8906702

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Anatomical Site, Viral Ribonucleic Acid Abundance, and Time of Sampling Correlate With Molecular Detection of Severe Acute Respiratory Syndrome Coronavirus 2 During Infection.

Lantry FJ, Epsi NJ, Pollett SD, Simons MP, Lindholm DA, Colombo RE, Fries AC, Maves RC, Ganesan A, Utz GC, Lalani T, Smith AG, Mody RM, Colombo CJ, Chi SW, Madar C, Huprikar N, Larson DT, Bazan S, [...] EPICC COVID-19 Cohort Study Group

Open Forum Infect Dis, 9(3):ofab623, 08 Dec 2021

Cited by: 1 article | PMID: 35141345 | PMCID: PMC8689744

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Durability of SARS-CoV-2-Specific T-Cell Responses at 12 Months Postinfection.

Lu Z, Laing ED, Pena DaMata J, Pohida K, Tso MS, Samuels EC, Epsi NJ, Dorjbal B, Lake C, Richard SA, Maves RC, Lindholm DA, Rozman JS, English C, Huprikar N, Mende K, Colombo RE, Colombo CJ, Broder CC, [...] EPICC COVID-19 Cohort Study Group

J Infect Dis, 224(12):2010-2019, 01 Dec 2021

Cited by: 27 articles | PMID: 34673956 | PMCID: PMC8672777

Add to export list Free full text in Europe PMC

458. A Machine Learning Approach Identifies Distinct Early-Symptom Cluster Phenotypes Which Correlate with Severe SARS-CoV-2 Outcomes

Epsi N, Powers J, Lindholm D, Lindholm D, Helfrich A, Huprikar N, Ganesan A, Lalani T, Mody R, Madar C, Bazan S, Colombo R, Larson D, Maves R, Maves R, Utz G, Tribble D, Agan B, Burgess T, [...] Richard S

Open Forum Infect Dis, 8(suppl 1):S331-S332, 01 Nov 2021

Cited by: 0 articles | PMCID: PMC8644530

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

34. Long-term clinical outcomes following SARS-CoV-2 infection include persistent symptoms and cardiovascular disease beyond 3 months post-infection

Richard S, Pollett S, Epsi N, Maves R, Maves R, Utz G, Lalani T, Mody R, Ganesan A, Colombo R, Colombo C, Lindholm D, Lindholm D, Madar C, Chi S, Huprikar N, Larson D, Bazan S, Byrne C, [...] Agan B

Open Forum Infect Dis, 8(suppl 1):S24-S25, 01 Nov 2021

Cited by: 0 articles | PMCID: PMC8644356

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Predictive Value of an Age-Based Modification of the National Early Warning System in Hospitalized Patients With COVID-19.

Maves RC, Richard SA, Lindholm DA, Epsi N, Larson DT, Conlon C, Everson K, Lis S, Blair PW, Chi S, Ganesan A, Pollett S, Burgess TH, Agan BK, Colombo RE, Colombo CJ, EPICC COVID-19 Cohort Study Group

Open Forum Infect Dis, 8(12):ofab421, 10 Aug 2021

Cited by: 3 articles | PMID: 34877361 | PMCID: PMC8643671

Add to export list Free full text in Europe PMC

337. SARS-CoV-2 Viral Load Does Not Predict Incident Venous Thromboembolism in COVID-19

Pollett S, Wier B, Richard S, Fries A, Maves R, Maves R, Utz G, Lalani T, Mody R, Ganesan A, Colombo R, Colombo C, Lindholm D, Lindholm D, Madar C, Chi S, Huprikar N, Larson D, Bazan S, [...] Burgess T

Open Forum Infect Dis, 8(suppl 1):S273-S273, 01 Nov 2021

Cited by: 0 articles | PMCID: PMC8690504

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Clinical, Immunological, and Virological SARS-CoV-2 Phenotypes in Obese and Nonobese Military Health System Beneficiaries.

Epsi NJ, Richard SA, Laing ED, Fries AC, Millar E, Simons MP, English C, Colombo CJ, Colombo RE, Lindholm DA, Ganesan A, Maves RC, Huprikar N, Larson D, Mende K, Chi SW, Madar C, Lalani T, Broder CC, [...] EPICC COVID-19 Cohort Study Group

J Infect Dis, 224(9):1462-1472, 01 Nov 2021

Cited by: 12 articles | PMID: 34331541 | PMCID: PMC8385847

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trial.

Kalil AC, Mehta AK, Patterson TF, Erdmann N, Gomez CA, Jain MK, Wolfe CR, Ruiz-Palacios GM, Kline S, Regalado Pineda J, Luetkemeyer AF, Harkins MS, Jackson PEH, Iovine NM, Tapson VF, Oh MD, Whitaker JA, Mularski RA, Paules CI, [...] ACTT-3 study group members

Lancet Respir Med, 9(12):1365-1376, 18 Oct 2021

Cited by: 102 articles | PMID: 34672949 | PMCID: PMC8523116

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

SARS-CoV-2 antibodies remain detectable 12 months after infection and antibody magnitude is associated with age and COVID-19 severity

Laing ED, Epsi NJ, Richard SA, Samuels EC, Wang W, Vassell R, Ewing DF, Herrup R, Sterling SL, Lindholm DA, Millar EV, Maves RC, Larson DT, Colombo RE, Chi S, Madar C, Lalani T, Ganesan A, Fries A, [...] for the EPICC Study team

medRxiv, 02 May 2021

Cited by: 0 articles | PPR: PPR319658

Add to export list Preprint

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Intensive Care Unit-Like Care of Nonhuman Primates with Ebola Virus Disease.

Blair PW, Kortepeter MG, Downey LG, Madar CS, Downs IL, Martins KA, Rossi F, Williams JA, Madar A, Schellhase CW, Bearss JJ, Zeng X, Bavari S, Soloveva V, Wells JB, Stuthman KS, Garza NL, Vantongeren SA, Donnelly GC, [...] Cardile AP

J Infect Dis, 224(4):632-642, 01 Aug 2021

Cited by: 3 articles | PMID: 33367826 | PMCID: PMC8366444

Add to export list Free full text in Europe PMC

508. Biomarker elevation during COVID-19: Differences between ambulatory and hospitalized individuals

Blair P, Lanteri C, Striegel D, Agan B, Maves R, Chenoweth J, Larson D, Mende K, Colombo R, Lindholm D, Ganesan A, Richard S, Colombo C, Madar C, Huprikar N, Tribble D, Dumler J, Burgess T, Burgess T, Clark D

Open Forum Infect Dis, 7(suppl 1):S319-S320, 01 Oct 2020

Cited by: 0 articles | PMCID: PMC7778285

Add to export list

This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.

Free full text in Europe PMC

Histological Diagnoses of Military Personnel Undergoing Lung Biopsy After Deployment to Southwest Asia.

Madar CS, Lewin-Smith MR, Franks TJ, Harley RA, Klaric JS, Morris MJ

Lung, 195(4):507-515, 23 May 2017

Cited by: 6 articles | PMID: 28536739

Add to export list

Search life-sciences literature (45,100,050 articles, preprints and more)

Search results

Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials.

Peripapillary hyperreflective ovoid mass-like structures and the retinal nerve fiber layer thinning.

Decreased Self-reported Physical Fitness Following SARS-CoV-2 Infection and the Impact of Vaccine Boosters in a Cohort Study.

Weakly Semi-Supervised Detection in Lung Ultrasound Videos

Understanding "Hybrid Immunity": Comparison and Predictors of Humoral Immune Responses to Severe Acute Respiratory Syndrome Coronavirus 2 Infection (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19) Vaccines.

Persistent COVID-19 Symptoms at 6 Months After Onset and the Role of Vaccination Before or After SARS-CoV-2 Infection.

Distinct blood inflammatory biomarker clusters stratify host phenotypes during the middle phase of COVID-19.

[Junctional scotoma of Traquair as presenting sign of a pituitary adenoma].

An Analysis of SARS-CoV-2 Vaccine Reactogenicity: Variation by Type, Dose, and History, Severity, and Recency of Prior SARS-CoV-2 Infection.

COVID-19 Patient-Reported Symptoms Using FLU-PRO Plus in a Cohort Study: Associations With Infecting Genotype, Vaccine History, and Return to Health.

COVID-19 Outcomes Among US Military Health System Beneficiaries Include Complications Across Multiple Organ Systems and Substantial Functional Impairment.

Performance of the inFLUenza Patient-Reported Outcome Plus (FLU-PRO Plus) Instrument in Patients With Coronavirus Disease 2019.

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA Vaccine-Breakthrough Infection Phenotype Includes Significant Symptoms, Live Virus Shedding, and Viral Genetic Diversity.

Anatomical Site, Viral Ribonucleic Acid Abundance, and Time of Sampling Correlate With Molecular Detection of Severe Acute Respiratory Syndrome Coronavirus 2 During Infection.

Durability of SARS-CoV-2-Specific T-Cell Responses at 12 Months Postinfection.

458. A Machine Learning Approach Identifies Distinct Early-Symptom Cluster Phenotypes Which Correlate with Severe SARS-CoV-2 Outcomes

34. Long-term clinical outcomes following SARS-CoV-2 infection include persistent symptoms and cardiovascular disease beyond 3 months post-infection

Predictive Value of an Age-Based Modification of the National Early Warning System in Hospitalized Patients With COVID-19.

337. SARS-CoV-2 Viral Load Does Not Predict Incident Venous Thromboembolism in COVID-19

Clinical, Immunological, and Virological SARS-CoV-2 Phenotypes in Obese and Nonobese Military Health System Beneficiaries.

Efficacy of interferon beta-1a plus remdesivir compared with remdesivir alone in hospitalised adults with COVID-19: a double-bind, randomised, placebo-controlled, phase 3 trial.

SARS-CoV-2 antibodies remain detectable 12 months after infection and antibody magnitude is associated with age and COVID-19 severity

Intensive Care Unit-Like Care of Nonhuman Primates with Ebola Virus Disease.

508. Biomarker elevation during COVID-19: Differences between ambulatory and hospitalized individuals

Histological Diagnoses of Military Personnel Undergoing Lung Biopsy After Deployment to Southwest Asia.

Partnerships & funding